Pulmonology

At ADDUCO PHARMACEUTICALS PRIVATE LIMITED, contributes significantly to the field of pulmonology by providing essential therapies for severe respiratory conditions and infections. Our connection to this therapy area is driven by our mission of "Inducing Life," ensuring that patients with compromised lung health have access to high-efficacy medical solutions.

Therapeutic Contributions

We support pulmonology through a specialized portfolio focused on managing acute and life-threatening respiratory challenges:

• Management of Severe Lung Infections: Our portfolio includes advanced anti-infectives designed to treat serious respiratory infections
• Critical Respiratory Support: We provide essential pharmaceutical injections, which is used to manage acute inflammatory responses in the lungs.
• Combatting Multi-Drug Resistance: In cases of severe pulmonary complications involving drug-resistant bacteria, we offer high-end treatments to help clinicians achieve better patient outcomes.
• Specialized Antibiotic Support: Our range of carbapenems and combinations, provides critical support in hospital settings for treating complex pulmonary infections.
• Injectable Therapies for Acute Crisis: In critical care settings, our specialized injectables provide rapid intervention for severe respiratory distress. This includes high-potency anti-inflammatories, used to manage acute lung inflammation.
• Targeted Anti-Infectives: We offer advanced injectable antibiotics, including carbapenems and last-resort anti-infectives to treat severe infections such as Ventilator-Associated Pneumonia (VAP).

Integrated Care Infrastructure

Beyond individual therapies, our infrastructure ensures that these vital treatments are developed and delivered with the highest integrity: